MIR3136

Across TCGA pan-cancer cohorts, MIR3136 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR3136 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MIR3136 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3136 expression acts as an unfavorable survival marker, although some lineages such as LAML and LUAD show a favorable association.

DLBC, TGCT, and CESC are the cancer types where MIR3136 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	All	0.504	0.936	<.001	90	view →
TGCT	OS	Tertile	All	0.902	1.000	<.001	54	view →
CESC	OS	Tertile	III,IV	0.508	0.800	.007	54	view →
THCA	OS	Tertile	II,III,IV	0.939	0.990	<.001	46	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	36	view →
READ	DFS	Tertile	IV	0.217	0.660	.002	36	view →
HNSC	OS	Tertile	III,IV	0.156	0.357	.006	27	view →
LAML	DFS	Tertile	All	0.619	0.252	.002	18	view →
LUAD	DFS	Median	III,IV	0.806	0.532	.016	15	view →
LUSC	OS	Tertile	III,IV	0.508	0.709	.022	15	view →
ACC	DFS	Tertile	III,IV	0.965	0.317	.013	15	view →
PAAD	DFS	Quartile	II,III,IV	0.348	0.478	.013	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MIR3136–DLBC (OS)

Open the DLBC breakdown →